HEAD AND NECK (HNSCC)

Clinical trials for HEAD AND NECK (HNSCC) explained in plain language.

Never miss a new study

Get alerted when new HEAD AND NECK (HNSCC) trials appear

Sign up with your email to follow new studies for HEAD AND NECK (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

New pastille could change head and neck cancer treatment

Disease control Not yet recruiting

This large Phase 3 trial is testing a new drug called APG-157, given as a pastille that dissolves in the mouth, for people with advanced head and neck cancer. The study will see if adding APG-157 before and after standard treatments (surgery or chemoradiation) helps keep the canc…

Matched conditions: HEAD AND NECK (HNSCC)

Phase: PHASE3 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control

Last updated Jul 02, 2026 04:00 UTC

HEAD AND NECK (HNSCC)

Get alerted when new HEAD AND NECK (HNSCC) trials appear

New pastille could change head and neck cancer treatment